XFRA ISIN CHANGE

Einstellung Aufnahme
ISIN Name Einstellung mit Ablauf: ISIN Name Ab dem: Anmerkungen
FR0012816825 Biophytis 02.05.2024 FR001400OLP5 Biophytis 03.05.2024 Tausch 400:1
US98585K8624 Yield10 Bioscience Inc. 02.05.2024 US98585K8541 Yield10 Bioscience Inc. 03.05.2024 Tausch 24:1
CA03949L2003 NorthX Nickel Corp. 02.05.2024 CA66860Q1028 NorthX Nickel Corp. 03.05.2024 Tausch 6:1
CA0079755017 AEterna Zentaris Inc. 02.05.2024 CA0079756007 AEterna Zentaris Inc. 03.05.2024 Tausch 4:1
US78418A5056 Safe & Green Holdings Corp. 02.05.2024 US78418A6047 Safe & Green Holdings Corp. 03.05.2024 Tausch 20:1

Treibt Nvidias KI-Boom den Uranpreis?

In einer Welt, in der künstliche Intelligenz zunehmend zum Treiber technologischer Fortschritte wird, rückt auch der Energiebedarf, der für den Betrieb und die Weiterentwicklung von KI-Systemen erforderlich ist, in den Fokus.

Nvidia, ein Vorreiter auf dem Gebiet der KI, steht im Zentrum dieser Entwicklung. Mit steigender Nachfrage nach leistungsfähigeren KI-Anwendungen steigt auch der Bedarf an Energie. Uran, als Schlüsselkomponente für die Energiegewinnung in Kernkraftwerken, könnte dadurch einen neuen Stellenwert erhalten.

Dieser kostenlose Report beleuchtet, wie der KI-Boom potenziell den Uranmarkt beeinflusst und stellt drei aussichtsreiche Unternehmen vor, die von diesen Entwicklungen profitieren könnten und echtes Rallyepotenzial besitzen

Handeln Sie Jetzt!

Fordern Sie jetzt den brandneuen Spezialreport an und profitieren Sie von der steigenden Nachfrage, der den Uranpreis auf neue Höchststände treiben könnte.

Hier klicken

Zeit	Aktuelle Nachrichten
11.10.	Biophytis GAAP EPS of -€9.48
30.09.	Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities	PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / September 30, 2024 / Biophytis SA (Euronext Growth Paris:ALBPS) ("Biophytis" or the "Company"), a clinical-stage biotechnology company focused on developing... ► Artikel lesen
30.09.	BIOPHYTIS: Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities
30.09.	Biophytis SA - 6-K, Report of foreign issuer
22.07.	Biophytis SA - 6-K, Report of foreign issuer

Zeit

Aktuelle Nachrichten

11.10.

Biophytis GAAP EPS of -€9.48

30.09.

Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities

PARIS, FRANCE and CAMBRIDGE, MA / ACCESSWIRE / September 30, 2024 / Biophytis SA (Euronext Growth Paris:ALBPS) ("Biophytis" or the "Company"), a clinical-stage biotechnology company focused on developing...
► Artikel lesen

30.09.

BIOPHYTIS: Biophytis Publishes First-Half Financial Results and Provides an Update on its Business Activities

30.09.

Biophytis SA - 6-K, Report of foreign issuer

22.07.

Biophytis SA - 6-K, Report of foreign issuer

Zeit	Aktuelle Nachrichten
12.11.	COSCIENS Biopharma Inc. Reports Third Quarter 2024 Financial Results and Provides Update on Advancements with Merger Integration Process and Ongoing Development Programs	Continued execution on merger integration with Ceapro Inc. and advancements across business Company ended the quarter with US$20.0 million in cash TORONTO, ONTARIO, Nov. 12, 2024 (GLOBE... ► Artikel lesen
12.11.	COSCIENS Biopharma Inc. - 6-K, Report of foreign issuer
08.10.	Cosciens Biopharma Inc: Cosciens Biopharma director Egbert resigns
08.10.	COSCIENS Biopharma strukturiert Vorstand um
08.10.	COSCIENS Biopharma reshuffles board of directors

Zeit

Aktuelle Nachrichten

12.11.

COSCIENS Biopharma Inc. Reports Third Quarter 2024 Financial Results and Provides Update on Advancements with Merger Integration Process and Ongoing Development Programs

Continued execution on merger integration with Ceapro Inc. and advancements across business Company ended the quarter with US$20.0 million in cash TORONTO, ONTARIO, Nov. 12, 2024 (GLOBE...
► Artikel lesen

12.11.

COSCIENS Biopharma Inc. - 6-K, Report of foreign issuer

08.10.

Cosciens Biopharma Inc: Cosciens Biopharma director Egbert resigns

08.10.

COSCIENS Biopharma strukturiert Vorstand um

08.10.

COSCIENS Biopharma reshuffles board of directors

Zeit	Aktuelle Nachrichten
04.11.	NEOGAP and NorthX Biologics partner for cancer cell therapy production
04.11.	NEOGAP THERAPEUTICS AB: Neogap Therapeutics partners with NorthX Biologics to advance scalable manufacturing for its novel cancer cell therapy
11.09.	LIPUM AB: Lipum and NorthX Biologics - a deep dive into the collaboration and production process
08.07.	Northx Nickel Corp: Northx Nickel talks Grasset 2023/2024 drilling
08.07.	NorthX Nickel Corp.: NorthX Nickel Provides Exploration Update on the Grasset Nickel Project	Vancouver, British Columbia--(Newsfile Corp. - July 8, 2024) - NorthX Nickel Corp. (CSE: NIX) (OTCQB: NXNIF) (FSE: 6YR) (the "Company" or "NorthX") is pleased to provide a summary of the drilling completed... ► Artikel lesen

Zeit

Aktuelle Nachrichten

04.11.

NEOGAP and NorthX Biologics partner for cancer cell therapy production

04.11.

NEOGAP THERAPEUTICS AB: Neogap Therapeutics partners with NorthX Biologics to advance scalable manufacturing for its novel cancer cell therapy

11.09.

LIPUM AB: Lipum and NorthX Biologics - a deep dive into the collaboration and production process

08.07.

Northx Nickel Corp: Northx Nickel talks Grasset 2023/2024 drilling

08.07.

NorthX Nickel Corp.: NorthX Nickel Provides Exploration Update on the Grasset Nickel Project

Vancouver, British Columbia--(Newsfile Corp. - July 8, 2024) - NorthX Nickel Corp. (CSE: NIX) (OTCQB: NXNIF) (FSE: 6YR) (the "Company" or "NorthX") is pleased to provide a summary of the drilling completed...
► Artikel lesen

Zeit	Aktuelle Nachrichten
Fr	SAFE & GREEN HOLDINGS CORP. - 8-K, Current Report
Do	Hanwha Ocean SG Holdings Secures 95.15% Stake in Dyna-Mac Holdings
Mi	SG Blocks stock plunges to 52-week low of $0.49 amid market challenges
14.11.	SAFE & GREEN HOLDINGS CORP. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB
08.11.	Aegis Capital Corp. Acted as Exclusive Placement Agent on a ~$2.4 Million Warrant Inducement for Safe & Green Holdings Corp.	NEW YORK, NY / ACCESSWIRE / November 8, 2024 / Aegis Capital Corp. acted as Exclusive Placement Agent on a ~$2.4 Million Warrant Inducement for Safe & Green Holdings Corp. (NASDAQ:SGBX).About for Safe... ► Artikel lesen

Zeit

Aktuelle Nachrichten

SAFE & GREEN HOLDINGS CORP. - 8-K, Current Report

Hanwha Ocean SG Holdings Secures 95.15% Stake in Dyna-Mac Holdings

SG Blocks stock plunges to 52-week low of $0.49 amid market challenges

14.11.

SAFE & GREEN HOLDINGS CORP. - NT 10-Q, Notification of inability to timely file Form 10-Q or 10-QSB

08.11.

Aegis Capital Corp. Acted as Exclusive Placement Agent on a ~$2.4 Million Warrant Inducement for Safe & Green Holdings Corp.

NEW YORK, NY / ACCESSWIRE / November 8, 2024 / Aegis Capital Corp. acted as Exclusive Placement Agent on a ~$2.4 Million Warrant Inducement for Safe & Green Holdings Corp. (NASDAQ:SGBX).About for Safe...
► Artikel lesen

Zeit	Aktuelle Nachrichten
Fr	YIELD10 BIOSCIENCE, INC. - 8-K, Current Report
12.11.	YIELD10 BIOSCIENCE, INC. - 8-K, Current Report
08.11.	Yield10 Bioscience, Inc.: Yield10 Bioscience Announces Adjournment of Special Meeting of Stockholders to Solicit Sufficient Votes in Favor of the Key Proposals	Special Meeting Adjourned to Thursday, November 21, 2024 WOBURN, MA / ACCESSWIRE / November 8, 2024 / Yield10 Bioscience, Inc. (OTCQB:YTEN) ("Yield10" or the "Company"), an agricultural bioscience... ► Artikel lesen
31.10.	YIELD10 BIOSCIENCE, INC. - 8-K, Current Report
03.10.	YIELD10 BIOSCIENCE, INC. - 8-K, Current Report

Zeit

Aktuelle Nachrichten

YIELD10 BIOSCIENCE, INC. - 8-K, Current Report

12.11.

YIELD10 BIOSCIENCE, INC. - 8-K, Current Report

08.11.

Yield10 Bioscience, Inc.: Yield10 Bioscience Announces Adjournment of Special Meeting of Stockholders to Solicit Sufficient Votes in Favor of the Key Proposals

Special Meeting Adjourned to Thursday, November 21, 2024 WOBURN, MA / ACCESSWIRE / November 8, 2024 / Yield10 Bioscience, Inc. (OTCQB:YTEN) ("Yield10" or the "Company"), an agricultural bioscience...
► Artikel lesen

31.10.

YIELD10 BIOSCIENCE, INC. - 8-K, Current Report

03.10.

YIELD10 BIOSCIENCE, INC. - 8-K, Current Report

Unternehmen / Aktien	Kurs	%
BIOPHYTIS SA	0,280	-0,07 %
COSCIENS BIOPHARMA INC	2,580	-9,79 %
NORTHX NICKEL CORP	0,062	+21,57 %
SAFE & GREEN HOLDINGS CORP	0,522	+1,24 %
YIELD10 BIOSCIENCE INC	0,184	0,00 %

Unternehmen / Aktien

Kurs

BIOPHYTIS SA

0,280

-0,07 %

COSCIENS BIOPHARMA INC

2,580

-9,79 %

NORTHX NICKEL CORP

0,062

+21,57 %

SAFE & GREEN HOLDINGS CORP